Skip to main content
LifeTech Scientific Corporation logo

LifeTech Scientific Corporation — Investor Relations & Filings

Ticker · 1302 ISIN · KYG548721177 LEI · 6556002IU4863JGD4A38 HKEX Manufacturing
Open in API
Filings indexed 574 across all filing types
Latest filing 2026-05-22 M&A Activity
Country KY Cayman Islands
Listing HKEX 1302

About LifeTech Scientific Corporation

http://www.lifetechmed.com

LifeTech Scientific Corporation is a developer, manufacturer, and marketer of advanced minimally invasive interventional medical devices. The company specializes in providing innovative solutions for the treatment of complex conditions, primarily focusing on structural heart diseases, peripheral vascular diseases, and cardio-cerebrovascular diseases. Its core business involves the R&D, production, and sale of high-quality devices designed for minimally invasive surgical procedures, driving solid development through continuous innovation.

Recent filings

Filing Released Lang Actions
MAJOR TRANSACTION - PROPOSED ACQUISITION OF APPROXIMATELY 96.46% EQUITY INTEREST IN STARWAY MEDICAL TECHNOLOGY, INC. * INVOLVING ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE
M&A Activity Classification · 93% confidence The document is a Hong Kong Stock Exchange announcement by LifeTech Scientific Corporation concerning a “Major Transaction” – the proposed acquisition of ~96.46% equity interest in Starway Medical Technology through issuance of convertible bonds under a specific mandate. It provides detailed terms of the acquisition framework agreement and convertible bonds, meeting Listing Rules requirements for a major transaction announcement. This fits the definition of M&A Activity (Code: TAR) – announcements and documents related to merger proposals or takeover bids.
2026-05-22 English
List of Directors and their Roles and Functions
Board/Management Information Classification · 85% confidence The document is a public announcement listing the company’s board composition and committee memberships. It does not present financial data, transcripts, or refer to publication of another report, but rather directly discloses board and management roles. This fits the Board/Management Information category (MANG).
2026-05-22 English
RESIGNATION OF EXECUTIVE DIRECTORS, AUTHORISED REPRESENTATIVE AND MEMBER OF THE NOMINATION COMMITTEE
Board/Management Information Classification · 87% confidence The document is a public announcement by LifeTech Scientific Corporation regarding the resignation of two executive directors, an authorised representative and a nomination committee member. This is a change in the company’s board and senior management. Therefore, it fits the “Board/Management Information” category.
2026-05-22 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-07 English
Notification Letter and Reply Form for Registered Shareholders
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 6 May 2026 from LifeTech Scientific Corporation to its registered shareholders. It informs shareholders about the publication of corporate communications including a circular related to general mandates to issue and repurchase shares, re-election of directors, continuous appointment of independent non-executive directors, and notice of the Annual General Meeting, as well as the proxy form. The letter directs shareholders to the company's website and the Stock Exchange website to access these documents and offers shareholders the option to receive printed copies. The document also includes a reply form for shareholders to indicate their preferences for receiving future corporate communications. The content is primarily an announcement about the availability and distribution of other corporate documents rather than the documents themselves. It does not contain financial statements, management discussion, or detailed report content. The document is relatively short and serves as a notification of publication and distribution method for other reports and communications. Therefore, according to the "Menu vs Meal" rule and the nature of the content, this document should be classified as a Report Publication Announcement (RPA).
2026-05-06 English
Notification Letter and Request Form for Non-Registered Shareholders
Report Publication Announcement Classification · 100% confidence The document is a notification letter dated 6 May 2026 from LifeTech Scientific Corporation addressed to non-registered shareholders. It informs them about the publication of a Circular related to general mandates to issue and repurchase shares, re-election of directors, continuous appointment of independent non-executive directors, and notice of the Annual General Meeting (AGM). The letter directs shareholders to the company's website and the Stock Exchange website to access the full Circular and AGM notice. It also includes a request form for shareholders to choose how to receive future corporate communications. The document does not contain the Circular itself, financial statements, or detailed report content but is an announcement about the availability of these materials. It is essentially a notice of publication of a corporate communication document and instructions for shareholders on how to receive it. According to the classification rules, such a document is a Report Publication Announcement (RPA) because it announces the publication of a report (Circular and AGM notice) without containing the report itself or substantive financial data.
2026-05-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.